Makoto Ohtake to Glioma
This is a "connection" page, showing publications Makoto Ohtake has written about Glioma.
Connection Strength
0.329
-
Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma. Ann Nucl Med. 2018 May; 32(4):264-271.
Score: 0.137
-
(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET. AJNR Am J Neuroradiol. 2014 Feb; 35(2):278-84.
Score: 0.100
-
Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):47-52.
Score: 0.092